Tara Gelb

Title: Tara Gelb - Innovator in Bicyclic Peptide Ligands

Introduction

Tara Gelb is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biochemistry, particularly in the development of peptide ligands. Her work focuses on innovative solutions for medical applications, showcasing her dedication to advancing healthcare.

Latest Patents

Tara Gelb holds a patent for "Bicyclic peptide ligands specific for Nectin-4." This invention relates to polypeptides that are covalently bound to molecular scaffolds, allowing for the formation of two or more peptide loops between attachment points. The peptides described in her patent are high-affinity binders of Nectin-4. Additionally, the invention includes drug conjugates comprising these peptides, which can be conjugated to effector and/or functional groups. The pharmaceutical compositions derived from these peptide ligands and drug conjugates are intended for use in preventing, suppressing, or treating diseases mediated by Nectin-4.

Career Highlights

Tara Gelb is associated with Bicycletx Limited, where she continues to innovate and develop her research. Her work has garnered attention in the scientific community, and she is recognized for her contributions to peptide research.

Collaborations

Tara collaborates with Liuhong Chen, who is also involved in the research and development of peptide ligands. Their partnership enhances the potential for groundbreaking discoveries in their field.

Conclusion

Tara Gelb's innovative work in bicyclic peptide ligands represents a significant advancement in medical research. Her contributions are paving the way for new therapeutic options in treating diseases associated with Nectin-4.